18th May 2018
- 0 comments
Spherium Biomed has disclosed the top line results of its Phase II clinical trial of Mucomel®, an oral gel for the prevention and treatment of oral mucositis in head and neck cancer patients undergoing chemo/bio-radiotherapy.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage